Accelerating Innovation at Leica Biosystems

Reinforcing Our Competitive Advantage at LBS & Radiometer COMMERCIAL EXECUTION DBS "Commercial Playbook" - Daily Management, Growth Room, Key Account Management Installed base annual growth +DD since 2018: Leica BIOSYSTEMS RADIOMETERER CORE REVENUE GROWTH VS PEERS Avg. Annual Core Revenue Growth 2018 - 2021E RADIOMETER R LBS BOND INSTRUMENTS +HSD RAD. BLOOD GAS ANALYZERS PEERS +MSD +HSD DIGITAL INNOVATION Leica BIOSYSTEMS +HSD Results since >50% 2018: DIGITAL PATHOLOGY REVENUE GROWTH AT LBS +3X CONNECTED BLOOD GAS ANALYZERS AT RADIOMETER PEERS +MSD >250BPS AVG. ANNUAL OUTPERFORMANCE VS PEERS Consistent, DBS-driven execution drives sustainable outperformance DANAHER

View entire presentation